BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:24 PM
Apr 03, 2007
 |  BC Extra  |  Clinical News

Icagen ends senicapoc trial

ICGN said it will end the Phase III ASSERT trial of senicapoc (formerly ICA-17043) to treat sickle cell anemia. The decision came after an IDMC recommended that the trial be terminated because of...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >